Regarding the action of quercetin in angiogenesis, it has been shown that it affects the VEGFR-2 mediated pathway, causing under-expression of the AKT (protein kinase B) regulatory factor, thus inhibiting blood vessel growth and restricting tumor growth in prostate and breast cancer [76]. This evidence concerns the gene AKT1 and breast carcinoma.